Yan Tang

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter by Type

Filter by Year

Filter by Focus Area

Filter by Solution

Search Results

Impact of medicare part D plan features on use of generic drugs

Opioid medication utilization and spending in medicare part d program

Improving Population Health Through Primary Care

If Medicare builds it, can FQHCs come?

Effect of web-based training for department of motor vehicle staff on donor designation rates: Results of a statewide randomized trial

Prescribing of clozapine and antipsychotic polypharmacy for schizophrenia in a large Medicaid program

Improvement in functional outcomes with adjunctive aripiprazole versus placebo in major depressive disorder: A pooled post hoc analysis of 3 short-term studies

Participation in a Medicare advanced primary care model and the delivery of high-value services

Patient, physician and organizational influences on variation in antipsychotic prescribing behavior

New study finds benefit of the Dispensary of Hope program in reducing health care costs

The concentration of antipsychotic prescribing: Evidence from Medicaid

Does access to free medication reduce health system costs? An evaluation of the Dispensary of Hope program

The Second Decade of Medicare Part D: Time to Modernize?

Urban employee basic medical insurance: Medical savings accounts and healthcare expenditures

Trend analysis of pharmaceutical expenditures in China

Regional variation in use of generic drugs and Medicare prescription drug cost sharing

Highly stable beneficiary attribution in Medicare’s Comprehensive Primary Care Plus model

Retaining part D's comprehensive coverage of antidepressants not a silver bullet

Use of clozapine and antipsychotic polypharmacy among patients with schizophrenia: Characterizing the prescribers